Enterprise Value
$12.22 B
+$32.40 M+0.27%
Fri, 07 Feb 2025 23:39:50 GMT
Summary
- As of February 9, 2025, BMRN enterprise value is $12.22 billion, with a rise of +$32.40 million (+0.27%) during the most recent trading day.
- Over the past year, BMRN enterprise value has dropped by -$5.37 billion (-30.55%).
- BMRN enterprise value is now -49.87% below its all-time high of $24.37 billion.
Performance
BMRN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
BMRN Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.3% | +0.3% | +0.3% |
| 1 m1 month | -1.0% | -1.0% | -1.0% |
| 3 m3 months | -3.8% | -3.8% | -3.8% |
| 6 m6 months | -26.2% | -25.2% | -25.3% |
| ytdytd | -3.2% | -3.2% | -3.2% |
| 1 y1 year | -30.6% | -28.8% | -29.5% |
| 5 y5 years | -23.6% | -21.1% | -25.5% |
BMRN Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -5.7% | $12 B | +5.2% | |
| 3 m | 3-month | $13 B | -5.7% | $12 B | +5.2% |
| 6 m | 6-month | $18 B | -33.0% | $12 B | +5.2% |
| 1 y | 1-year | $18 B | -33.0% | $12 B | +5.2% |
| 3 y | 3-year | $22 B | -45.2% | $12 B | +5.2% |
| 5 y | 5-year | $24 B | -49.9% | $12 B | +5.2% |
| alltime | all time | $24 B | -49.9% | $176 M | +6856.4% |
BioMarin Pharmaceutical Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $12.22 B(-3.2%) |
| 2024 | $12.62 B(-31.9%) |
| 2023 | $18.53 B(-5.5%) |
| 2022 | $19.60 B(+17.0%) |
| 2021 | $16.75 B(+2.3%) |
| 2020 | $16.37 B(+4.8%) |
| 2019 | $15.63 B(+0.7%) |
| 2018 | $15.51 B(-4.6%) |
| 2017 | $16.26 B(+11.5%) |
| 2016 | $14.58 B(-15.2%) |
| 2015 | $17.19 B(+29.8%) |
| 2014 | $13.25 B(+30.1%) |
| 2013 | $10.18 B(+60.1%) |
| Date | Value |
|---|---|
| 2012 | $6.36 B(+49.6%) |
| 2011 | $4.25 B(+30.0%) |
| 2010 | $3.27 B(+46.6%) |
| 2009 | $2.23 B(+5.1%) |
| 2008 | $2.12 B(-42.8%) |
| 2007 | $3.71 B(+125.3%) |
| 2006 | $1.64 B(+66.6%) |
| 2005 | $987.14 M(+47.4%) |
| 2004 | $669.92 M(+33.6%) |
| 2003 | $501.45 M(+45.1%) |
| 2002 | $345.53 M(-50.4%) |
| 2001 | $697.31 M(+104.3%) |
| 2000 | $341.23 M(-11.6%) |
| 1999 | $385.98 M |
FAQ
- What is BioMarin Pharmaceutical enterprise value?
- What is the all time high enterprise value for BioMarin Pharmaceutical?
- What is BMRN enterprise value year-to-date change?
- What is BioMarin Pharmaceutical enterprise value year-on-year change?
What is BioMarin Pharmaceutical enterprise value?
The current enterprise value of BMRN is $12.22 B
What is the all time high enterprise value for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high enterprise value is $24.37 B
What is BMRN enterprise value year-to-date change?
BioMarin Pharmaceutical enterprise value has changed by -$402.13 M (-3.19%) since the beginning of the year
What is BioMarin Pharmaceutical enterprise value year-on-year change?
Over the past year, BMRN enterprise value has changed by -$5.37 B (-30.55%)